Faculty
Darius Lakdawalla
University Professor of Pharmaceutical Economics and Public Policy
Quintiles Chair in Pharmaceutical Development and Regulatory Innovation
Chief Scientific Officer, USC Schaeffer Center
Programs
Education
Ph.D. in Economics, University of Chicago
Expertise
Health economics and health policy
The economics of risks to health
Value and determinants of medical innovation
The economics of health insurance markets
Industrial organization of healthcare markets
Biography
Darius Lakdawalla is a widely published, award-winning researcher and a leading authority on health economics and health policy. He is the University Professor of Pharmaceutical Economics and Public Policy and holds the Quintiles Chair in Pharmaceutical Development and Regulatory Innovation at the University of Southern California, where he sits on the faculties of the Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences and the Sol Price School of Public Policy. He is also the Chief Scientific Officer at USC’s Leonard D. Schaeffer Institute for Public Policy & Government Service, which develops evidence-based, non-partisan solutions for critical policy challenges, with a focus on health, economics, and social sciences. His research has focused primarily on the economics of risks to health, the value and determinants of medical innovation, the economics of health insurance markets, and the industrial organization of healthcare markets.
His academic work has appeared in leading peer-reviewed journals of economics, health policy, and medicine. His work has also been featured by prominent popular press outlets, such as the Wall Street Journal, National Public Radio, Forbes, and the New York Times. Dr. Lakdawalla received the PhRMA Foundation Value Assessment Challenge Award, designed to encourage innovative approaches to defining and measuring value in health care, in 2019 (third place) and 2020 (first place). He is the co-author of the recent book, Valuing Health: The Generalized and Risk-Adjusted Cost-Effectiveness (GRACE) Model, published by Oxford University Press. Dr. Lakdawalla is also an elected member (2025) of the National Academy of Medicine.
Selected Publications
- Mulligan,K., Baid, D., Maria-Alice Manetas, M.-A., … Lakdawalla, D., et al. (2025). Measuring the Budget Impact of Nondiscriminatory Cost-Effectiveness. JAMA Health Forum, 6(9).
- Bauer, D., Lakdawalla, D., & Reif, J. (2025). Health risk and the value of life. Journal of Public Economics, 245, 105346.
- Gracner, T., Chaturvedi, R., Nguyen, P., Heun‐Johnson, H., Tysinger, B., Goldman, D., & Lakdawalla, D. (2025). The burden of cognitive impairment. Alzheimer’s & Dementia, 21(8).
In The News
Cash.com
Lakdawalla quoted about President Trump’s drug pricing plan affecting European markets
Featured Faculty: Darius Lakdawalla
Bloomberg. com
Lakdawalla interviewed about drug manufacturers withholding medicines from European markets
Featured Faculty: Darius Lakdawalla
Drug Patent Watch
Lakdawalla’s research cited, in a story about the Inflation Reduction Act’s impact on pharmaceutical economics
Featured Faculty: Darius Lakdawalla
Affiliated Research Centers
Schaeffer Institute for Public Policy & Government Service
Kudos
March 10, 2026 Darius Lakdawalla, Professor of Pharmaceutical Economics and Public Policy, Quintiles Chair in Pharmaceutical Development and Regulatory Innovation, and Chief Scientific Officer, USC Schaeffer Center, is appointed a USC University Professorship for bringing great distinction and honor to USC through his work and research.
October 20, 2025 Darius Lakdawalla, Professor of Pharmaceutical Economics and Public Policy, chief scientific officer at the USC Schaeffer Center for Health Policy & Economics and Quintiles Chair of Pharmaceutical Development and Regulatory Innovation at the USC Mann School, is elected to the National Academy of Medicine.